drugset / Trial / NCT02006745

Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

NCT02006745

Phase 3 Completed 20 enrolled St Stephens Aids Trust
RandomizedParallel-groupOpen-labelHealth-services research

Summary

The purpose of the study is to explore the treatment of patients with acute hepatitis C infection (infection acquired within the last 6 months) who are also infected with human immunodeficiency virus (HIV).

Timeline

Start
2014-01
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Telaprevir Small molecule
Background Ribavirin Small molecule